News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
3
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
4
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
5